Thursday 12 June 2014
Olmesartan induced “Enteropathy”:
§ Olmesartan is an Angiotensin II receptor blocking (ARB) agent.
§ Since Olmesartan has a longer half-life and a greater effect on systolic blood pressure than other ARB agents, it is widely prescribed for the management of hypertension.
§ FDA warns that Olmesartan can cause intestinal problems known as sprue-like enteropathy (severe, chronic diarrhea with substantial weight loss).
§ Health care professionals should advise their patients to contact them if they develop severe, chronic diarrhea with substantial weight loss while taking an olmesartan-containing product, even if it takes months to years for symptoms to develop.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment